Send feedback

PRRT2 p.Arg295Gln

c.884G>A · rs1468206811 · VCV570056

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 4 submitters
AlphaMissense
likely pathogenic
0.7749 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00111%, sas)
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
episodic kinesigenic dyskinesia

⚠ Built without this gene's context — gene constraint and dosage, protein structure, pathways, panels and related-variant links were not looked up for this page. why

Computational evidence

Protein change
AlphaMissense0.7749likely pathogenic
REVEL0.774moderately pathogenic-leaning
SaProtLLR -11.57damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI—not looked up on this page · why
Constraint at this position
ConservationphyloP 12GERP 1.7, phastCons 1
Regional constrainto/e 0.90unconstrained · MANE · 709 bp · p 0.39 · regional, not allelic
Overall
CADD35.0PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00111% South Asian · 1/90,380 alleles
Filtering AF 0.000543% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000429%
Overall 0.000875% 14/1,600,816 alleles · very rare exomes 14/1,448,674 · genomes 0/152,142 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.00161% 62,178
South Asiangrpmax 0.00111% 90,380
European (non-Finnish) 0.00102% 98,127

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
PRRT2
Protein
p.Arg295Gln
Coding
c.884G>A
MANE Select
NM_145239
dbSNP
rs1468206811
Type
single nucleotide variant
Location
chr16:29814337 (GRCh38)
Full PRRT2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

episodic kinesigenic dyskinesia — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Paroxysmal kinesigenic dyskinesia (Orphanet):

Inheritance
Autosomal dominant, Not applicable
Onset
Adolescent, Adult, Childhood, Infancy
Prevalence
1-9 / 1 000 000 (Worldwide)

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/prrt2-p-arg295gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown